StreetAlpha
13F holdings · Q3 2026

Tang Capital Management

San Diego, CA · files as Tang Capital Management LLC
Know the moment Tang Capital Management filesYou follow Tang Capital Management An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Filed
Holdings as of Sep 30, 2026Filed Nov 16, 2026Next filing due Feb 15, 2027CIK 1232621

Tang Capital Management reported 44 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AUPH (9.8%), CORT (8.0%) and KNSA (7.8%). Compared with Q2 2026, the fund opened new positions in ARDX, VERA and LEGN, added to TARS, LKFT and CELC, trimmed SPY and sold out of CAPR and WVE.

Latest filing: what Tang Capital Management did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
6 new12 added1 trimmed2 sold outBought about $146M · sold about $124M
New 6
See all 6 →
Added 12
See all 12 →
Trimmed 1
  • SPY−$21.4M−23%
Sold out 2

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$2.2B−1.3% vs last quarter
Stocks held446 new · 2 sold out
Top 5 weight40.3%fairly concentrated
Turnover12%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
AUPH
Aurinia Pharmaceuticals Inc
$211M9.8%13MNo change8 of 8
2
CORT
Corcept Therapeutics Inc
$173M8.0%1.5MNo change4 of 8
3
KNSA
Kiniksa Pharmaceuticals Intl
$169M7.8%2.3MNo change8 of 8
4
SYRE
Spyre Therapeutics Inc
$168M7.8%1.9MNo change7 of 8
5
TARS
Tarsus Pharmaceuticals Inc
$151M7.0%1.9M+349K (+22%)8 of 8
6
LKFT
Galapagos NV
$118M5.5%4M+200K (+5%)8 of 8
7
CELC
Celcuity Inc
$116M5.4%1.5M+150K (+11%)5 of 8
8
MIRM
Mirum Pharmaceuticals Inc
$106M4.9%1.2MNo change8 of 8
9
PTCT
Ptc Therapeutics Inc
$97.2M4.5%1.5MNo change8 of 8
10
IMCR
Immunocore Hldgs PLC
$87.4M4.0%2.9M+235K (+9%)8 of 8
🔒 34 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
CAPR
Capricor Therapeutics Inc
$98.7M4.1M
WVE
Wave Life Sciences Ltd
$3.5M600K

Reported value

last 8 quarters
$1.5BQ4 '24
$1.8BQ1 '25
$2BQ2 '25
$2.6BQ3 '25
$2BQ4 '25
$2BQ1 '26
$2.2BQ2 '26
$2.2BQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 16, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Tang Capital Management 13F FAQ

What does Tang Capital Management own?

Tang Capital Management reported 44 stocks worth $2.2B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are AUPH (9.8%), CORT (8.0%) and KNSA (7.8%). The table above lists every position in the filing (the top 10 without an account).

What did Tang Capital Management buy and sell in Q3 2026?

Compared with Q2 2026: 6 new positions, 12 added to, 1 trimmed and 2 sold out. New positions include ARDX, VERA and LEGN. It sold all of CAPR and WVE.

When will Tang Capital Management file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Tang Capital Management's portfolio worth?

The Q3 2026 filing reports $2.2B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.